2) Bernard GR, Francois B, Mira JP, et al. Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock : randomized, double-blind, placebo-controlled phase IIb study. Crit Care Med. 2014 ; 42 : 504-11.